260 related articles for article (PubMed ID: 34354123)
1. A novel murine in vivo model for acute hereditary angioedema attacks.
Bupp S; Whittaker M; Lehtimaki M; Park J; Dement-Brown J; Zhou ZH; Kozlowski S
Sci Rep; 2021 Aug; 11(1):15924. PubMed ID: 34354123
[TBL] [Abstract][Full Text] [Related]
2. Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade.
Busse P; Kaplan A
J Allergy Clin Immunol Pract; 2022 Mar; 10(3):716-722. PubMed ID: 34838707
[TBL] [Abstract][Full Text] [Related]
3. Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment.
Zeerleder S; Levi M
Ann Med; 2016; 48(4):256-67. PubMed ID: 27018196
[TBL] [Abstract][Full Text] [Related]
4. Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema.
Davis AE
Ann Allergy Asthma Immunol; 2008 Jan; 100(1 Suppl 2):S7-12. PubMed ID: 18220146
[TBL] [Abstract][Full Text] [Related]
5. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis.
Joseph K; Tholanikunnel TE; Kaplan AP
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):50-4. PubMed ID: 20143645
[TBL] [Abstract][Full Text] [Related]
6. New treatment options for acute edema attacks caused by hereditary angioedema.
Thomas MC; Shah S
Am J Health Syst Pharm; 2011 Nov; 68(22):2129-38. PubMed ID: 22058099
[TBL] [Abstract][Full Text] [Related]
7. The role of the complement system in hereditary angioedema.
Csuka D; Veszeli N; Varga L; Prohászka Z; Farkas H
Mol Immunol; 2017 Sep; 89():59-68. PubMed ID: 28595743
[TBL] [Abstract][Full Text] [Related]
8. Dominant-negative SERPING1 variants cause intracellular retention of C1 inhibitor in hereditary angioedema.
Haslund D; Ryø LB; Seidelin Majidi S; Rose I; Skipper KA; Fryland T; Bohn AB; Koch C; Thomsen MK; Palarasah Y; Corydon TJ; Bygum A; Nejsum LN; Mikkelsen JG
J Clin Invest; 2019 Jan; 129(1):388-405. PubMed ID: 30398465
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of hereditary angioedema.
Canonica GW; Rossi O
Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for C1 esterase inhibitor deficiency in a Murine Model of Hereditary angioedema.
Qiu T; Chiuchiolo MJ; Whaley AS; Russo AR; Sondhi D; Kaminsky SM; Crystal RG; Pagovich OE
Allergy; 2019 Jun; 74(6):1081-1089. PubMed ID: 30059156
[TBL] [Abstract][Full Text] [Related]
11. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
Jacobs J; Neeno T
Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
[TBL] [Abstract][Full Text] [Related]
12. High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency.
Suffritti C; Zanichelli A; Maggioni L; Bonanni E; Cugno M; Cicardi M
Clin Exp Allergy; 2014 Dec; 44(12):1503-14. PubMed ID: 24552232
[TBL] [Abstract][Full Text] [Related]
13. Prospective, double-blind, placebo-controlled trials of ecallantide for acute attacks of hereditary angioedema.
Stolz LE; Sheffer AL
Expert Rev Clin Immunol; 2012 Jan; 8(1):25-32. PubMed ID: 22149337
[TBL] [Abstract][Full Text] [Related]
14. Ecallantide for treatment of acute hereditary angioedema attacks: analysis of efficacy by patient characteristics.
MacGinnitie AJ; Campion M; Stolz LE; Pullman WE
Allergy Asthma Proc; 2012; 33(2):178-85. PubMed ID: 22525395
[TBL] [Abstract][Full Text] [Related]
15. SERPING1 mutation update: Mutation spectrum and C1 Inhibitor phenotypes.
Ponard D; Gaboriaud C; Charignon D; Ghannam A; Wagenaar-Bos IGA; Roem D; López-Lera A; López-Trascasa M; Tosi M; Drouet C
Hum Mutat; 2020 Jan; 41(1):38-57. PubMed ID: 31517426
[TBL] [Abstract][Full Text] [Related]
16. Hereditary angioedema due to C1-inhibitor deficiency in Macedonia: clinical characteristics, novel SERPING1 mutations and genetic factors modifying the clinical phenotype.
Grivčeva-Panovska V; Košnik M; Korošec P; Andrejević S; Karadža-Lapić L; Rijavec M
Ann Med; 2018 May; 50(3):269-276. PubMed ID: 29513108
[TBL] [Abstract][Full Text] [Related]
17. Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks.
Hide M; Horiuchi T; Ohsawa I; Andresen I; Fukunaga A
Allergol Int; 2021 Jan; 70(1):45-54. PubMed ID: 32919903
[TBL] [Abstract][Full Text] [Related]
18. Angioedema attacks in patients with hereditary angioedema: Local manifestations of a systemic activation process.
Hofman ZL; Relan A; Zeerleder S; Drouet C; Zuraw B; Hack CE
J Allergy Clin Immunol; 2016 Aug; 138(2):359-66. PubMed ID: 27246526
[TBL] [Abstract][Full Text] [Related]
19. Changes of coagulation parameters during erythema marginatum in patients with hereditary angioedema.
Kőhalmi KV; Mező B; Veszeli N; Benedek S; Fehér A; Holdonner Á; Jesenak M; Varga L; Farkas H
Int Immunopharmacol; 2020 Apr; 81():106293. PubMed ID: 32078942
[TBL] [Abstract][Full Text] [Related]
20. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
